Company Comparison
Dermira vs 54gene
Side-by-side comparison of two portfolio companies — sector, funding stage, investors, valuation, and more.
| Metric | Dermira | 54gene |
|---|---|---|
| Sector | Biotech | Biotech |
| Headquarters | Menlo Park, CA | Lagos, Nigeria |
| Founded | 2010 | 2019 |
| Status | Active | Active |
| Last Funding Stage | IPO | Series B |
| Total Funding | $400M | $45M |
| Valuation | $1.1B | — |
What They Build
Dermira
Biopharmaceutical company focused on developing and commercializing novel therapeutics for dermatological conditions.
54gene
African genomics research company advancing precision medicine through genetic research focused on African populations.
Key Investors
Dermira
Sector Overlap
Both Dermira and 54gene operate in Biotech.
Browse all Biotech companies →Websites
Sponsored
AArchstone
The operating system for private capital.
Archstone runs the back office for venture, PE, real estate, and credit funds — LP reporting, capital calls, portfolio tracking, and fund accounting, in one platform. Now in alpha.
LP portal & reportingCapital callsPortfolio tracking$297/moNo AUM fees
Now in alpha with select funds. 14-day trial available.